Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

19/03/2026 08:00

Mar 19 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2026        Feb 28, 2025     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             50.56               46.58            66.80    
                 (+8.5 pct)          (+14.5 pct)      (+5.2 pct)  
  Operating        603 mln             95 mln             1.12    
                (+530.7 pct)         (-88.9 pct)     (+282.2 pct) 
  Recurring        419 mln           loss 18 mln        941 mln   
                                                     (+587.3 pct) 
  Net            loss 13 mln        loss 272 mln        266 mln   
  EPS           loss 1.20 yen      loss 24.06 yen      23.45 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T